Mathilde Hauge Lerche
Group leader, Associate Professor
Department of Health Technology
Building 349 Room 118
2800 Kgs. Lyngby
My research is strongly anchored on development of biomarkers, methods and equipment to enhance the utility of hyperpolarized metabolic contrast agents for in cell and in vivo magnetic resonance investigations. A central interest is understanding and finding effective solutions to the fundamental challenge of hyperpolarization – the short signal life-time. The conducted research is particularly tuned in on the field of biotechnology where technical engineering solutions, theoretical physics translated into practice and further optimized chemistry and biological application in recent years has led on studies of complex pathologies aiming at early diagnosis and monitoring of therapeutic effects.